Navigation Links
Q Fever IFA IgG

ProductsQ Fever IFA IgG
Company Focus Diagnostics
Item Q Fever IFA IgG
Features 
  • Focus Diagnostics Q fever Test Kits are packaged with sufficient materials to perform 80 determinations.
  • Each kit contains ten 8-well dual antigen substrate slides, class specific anti-human fluorescein conjugate, IgG or IgM as needed and negative and positive titered controls.
  • The Q fever IgM kit also includes a specially formulated sample pretreatment diluent.
  • In lieu of alternative pretreatments for IgM testing, the sample diluent is used to assist in the removal of interfering rheumatoid factor and/or competing IgG antibodies.
  • Both the Q fever IFA IgG kit and the Q fever IgM kit have a one-year shelf life from the date of manufacture.
Description Focus Diagnostics offers Q Fever IFA Test Kits for the detection and semi-quantitation of IgG and IgM human antibody responses to Coxiella burnetii. Our dual antigen-spot slide wells allow the simultaneous semi-quantitative detection and differentiation of antibodies to C. burnetii Phase I and Phase II antigens. By providing the two phases, Focus Diagnostics' Q Fever IFA Test Kits can aid in the differential diagnosis of primary vs. chronic Q fever infection.
Info Focus Diagnostics
Customer Service: 714-503-2003
Web site: http://www.focusdx.com

Related medicine products :

1. Q Fever IFA IgM
2. Cat Scratch Fever Antibodies, IgG
3. Cat Scratch Fever Antibodies, IgG & IgM
4. Cat Scratch Fever Antibodies, IgM
5. Colorado Tick Fever Antibodies, IgG & IgM, IFA
6. Coxiella burnetii (Q-Fever) Antibody IgG, Phase I & II by IFA
7. Coxiellaburnetii (Q-Fever) Antibody IgG, Phase II by IFA
8. Coxiella burnetii(Q-Fever) Antibody IgG, Phase I by IFA
9. Dengue Fever Virus Antibodies, IgG & IgM
10. Dengue Fever Virus Antibody, IgG
11. Dengue Fever Virus Antibody, IgM
TAG: Fever IFA IgG
... - Our networked solutions are delivered with a Ma...Never purchase software upgrades again; utilize ou...e ever-changing needs of your healthcare facility....tments have a mix of old and new equipment; we use...
...logy is the first digital solution designed specif...s both within and outside cardiology. From the ser...ions, Agfas combined expertise in both cine film a...to work the way they want, wherever they want.,Th...
Full Digital Ultrasound System UF-850XTD
Nemio
Medicine Products:
(Date:12/1/2009)...TRIANGLE PARK, N.C., Dec. 1 Max Ne...have expanded over the years serving the top most ...ich was originally set up in an area of 2000 sq. f...part of the suite of services by Max Neeman, are r...ble offering. ,, The pharmacy inventory managem...
(Date:12/1/2009)... Dec. 1 Individuals in ...ly than those with traditional coverage to exhibit...engaged in wellness programs, and to be more incli...olding down costs, according to survey results rel...search Institute (EBRI). ,, At the same time, ...
(Date:12/1/2009)...RDALE, Fla., Dec. 1 OrbusNeich tod...in the randomized clinical trial of the Combo Bio-...,, A prospective, randomized, multicenter study...u M inal sirolimus coat ED bio- E ngineered...ites in Asia, Australia, Europe and South America ...
(Date:12/1/2009)...California are unable to successfully obtain infor... despite recent state legislation intended to impr..., Posing as low-income uninsured patients, resea...-third of the hospitals they approached and the es... allowed under California law, according to the fi...
(Date:12/1/2009)... Lumension announces general availability of its ...ver end-to-end endpoint management capabilities on...nt console architecture. , ...sion, a global leader in endpoint management and s...dpoint Management and Security Suite (LEMSS) tha...
Breaking Medicine News(10 mins):Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 2Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 3Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 4Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 5Health News:New Lumension Endpoint Management and Security Suite To Deliver End-to-End Endpoint Management Capabilities 6
...lease is available in French . , A collaborati...ogical Institute (MNI), McGill University has demo... and cortical thickness in the brains of healthy 6... week in a special issue of scientific journal In...
...Texas, March 25 ULURU Inc. (NYSE Alternext: ULU) ...ce call to discuss the fourth quarter and year end...siness update on Tuesday, March 31, 2009 at 10:00 ...304#) five to ten minutes prior to the initiation ...
...e Call Today to Follow Release , , DENVER, March ... or the "Company") (OTC Bulletin Board: GLOB), an ...logy company, will report its fourth quarter and y...p://www.newscom.com/cgi-bin/prnh/20040226/GLOBALME...
...tive growths 3 times more likely regardless of age...h 25 (HealthDay News) -- Black women are three tim...p aggressive breast cancer, a U.S. study finds. , ...k women do get breast cancer, it,s often more adva...
...y 20 March, US researcher Dr. Chris Beecher from t...ture about sarcosine, an N-methyl derivative of th...ess in Stockholm, Sweden. Dr Beecher is a colleagu... with prostate cancer. These findings suggest that...
... March 25 An amazing medical discovery that provi... (ED) is in the US and looking to make the big th... News Release, go to: http://www.prnewswire.com/m...te Hydropump reverses Erectile Dysfunction throu...
Other Medicine News:Health News:When it comes to intelligence, size matters 2Health News:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2008 and to Provide a Business Update 2Health News:Global Med Technologies(R), Inc. to Report Fourth Quarter and Year End Financial Results Today 2Health News:Black Women at Higher Risk for Aggressive Breast Tumors 2Health News:A new approach to prostate cancer detection 2Health News:Video: Bathmate Hydropump Poised to Replace Cialis, Levitra, and Viagra 2
(Date:12/1/2009)..., , ALBUQUERQUE, N.M., Dec. 1 /PRNewswire/ -...s laboratory that discovers, develops and markets ...ointment of Scott Glenn as chairman of the company... ,, Prior to joining Exagen, Glenn was managing... of a number of successful biomedical companies in...
(Date:12/1/2009)..., , CHENGDU, China, Dec. 1 /PRNews..., Inc., (NYSE Amex: TPI ), a manufacturer and sup..."TCM") based in Chengdu, China, today,announced th...e Food and Drug,Administration (SFDA) to produce P...m of 10 ml/tube (SFDA approval number Z20093060) a...
(Date:12/1/2009)..., , BEIJING, Dec. 1 /PRNewswire-A...ding provider of biopharmaceutical products in Chi...h purchase order for its H1N1 vaccine, PANFLU.1(TM...on Technology for the national,purchase plan. Unde...uce an,additional one million doses of PANFLU.1 (T...
Breaking Medicine Technology:Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 2Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products 3Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 2Sinovac Obtains Fourth H1N1 Vaccine Order from Chinese Central Government 3Selective Insurance Group Announces Officer Appointments 56161 1Selective Insurance Group Announces Officer Appointments 56161 2Selective Insurance Group Announces Officer Appointments 56161 3XLHealth Appoints New Controller to Lead Financial Compliance Accounting Initiatives 56160 1XLHealth Appoints New Controller to Lead Financial Compliance Accounting Initiatives 56160 2Kroger Selects WaveSense Diabetes Testing Products 56156 1Kroger Selects WaveSense Diabetes Testing Products 56156 2